Research from Gilead Sciences Inc. Yields New Data on Remdesivir (Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19)

  • Jason Okulicz

Press/Media

Period3 Oct 2024

Media coverage

1

Media coverage

  • TitleResearch from Gilead Sciences Inc. Yields New Data on Remdesivir (Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19)
    Media name/outletNewsRx COVID-19 Daily
    Country/TerritoryUnited States
    Date3/10/24
    PersonsJason Okulicz
View all 1
View less